ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2010

Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosis.

David S Snyder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.